Detailed Programme
All times indicated are Hong Kong Time (UTC +8).
The programme is subject to change without prior notice.
Updated as of 20 May 2022.
Time |
Programme |
|
10:00 – 12:00 |
The union Asia Pacific Region Council Meeting (By invitation only) |
|
- |
- |
|
14:00 – 14:30 |
Opening Ceremony |
|
14:30 – 15:00 |
Keynote |
|
15:00 – 16:20 |
Plenary I – COVID-19 From SARS to COVID Accelerate the Research and Development of Anti-SARS-CoV-2 Drugs Against Different Mutant Strains |
Virtual Booth |
16:20 – 17:40 |
Plenary II – Tuberculosis The Colliding Pandemics of TB and COVID-19: Challenges and Opportunities Are We on Track to Reach End Tuberculosis Targets? |
|
17:40 – 18:20 |
Plenary III – Lung Health and Non-Communicable Diseases Improving Access to Effective Medicines for Asthma in Low-middle Income Countries |
|
Time |
Programme |
||
09:00 – 10:40 |
Symposium 1 – COVID-19 Will COVID-19 Transit from Pandemic to Endemic in 2022? Lessons from COVID-19 Omicron Outbreak in Hong Kong Development of Live Attenuated Vaccines for SARS-CoV-2 |
Symposium 2 – Lung Health and Non-Communicable Diseases Lung Health and Cardiometabolic Diseases Asthma in Asia Pacific Region Clinical Pearls in Chronic Obstructive Pulmonary Disease Management |
Virtual Booth |
10:40 – 10:55 |
Break |
||
10:55 – 12:35 |
Symposium 3 –Tuberculosis Treatment of Multidrug-Resistant Tuberculosis: Past and Present Diagnosis of Latent Tuberculosis Infection Clinical Utility of Target Amplicon Sequencing Test for Rapid Diagnosis of Drug Resistant Mycobacterium Tuberculosis from Respiratory Specimens |
Symposium 4 – Tobacco Control Overview of Bloomberg Initiative to Reduce Tobacco Use in Asia Pacific Region Smoking Cessation - Health System Challenges and Opportunities The Impact of Smoking and Cessation Effort on Tuberculosis Epidemic: Evidence from Previously Treated Tuberculosis Patients |
|
12:35 – 13:40 |
Lunch Break |
||
13:40 – 15:50 |
Symposium 5 – Other Lung Diseases Modified Qing-Zao-Jiu-Fei Decoction as a Novel Agent for Pneumoconiosis: Preclinical Evaluation on Its Efficacy and Action Mechanisms Screening and Preventive Treatment of Latent Tuberculosis Infection |
Symposium 6 – Lung Health and Non-Communicable Diseases Lung cancer screening – What Further Work Should be Done? Interplay of Diabetes and Tuberculosis: Hyperglycemia and More Obesity and Lung Health Can Chinese Medicine (CM) Treats Chronic Obstructive Pulmonary Disease (COPD): Efficacy, Safety and Introduction of CM Treatment Strategy |
|
15:50 – 16:00 |
Break |
||
16:00 – 18:10 |
Symposium 7 – Tuberculosis Addressing Post-Tuberculosis Health Assessment and Risk Factors in Routine Tuberculosis Service Are Novel Drugs Potent in the Treatment of Non-Tuberculous Mycobacteria Tuberculosis in Older Adults: A Review of Challenges and Best Practices in the Western Pacific Region Updates of Tuberculosis Diagnostics |
Oral Presentation Effects of Cigarette Smoke on SARS-CoV-2-Infected Primary Human Airway Epithelial Cells Long Term Predictors of Fatal Pneumonia in a General Japanese Population Close-to-Effortless Breathing Paradigm Identifies Lung Function Deterioration and Monitors Its Recovery Using a Portable and Self-Administrable Electrical Impedance Tomography System Cost Effectiveness Analysis on Expanding Tuberculosis Preventive Therapy to Household Contacts Aged 5-14 Years in the Philippines Comparison of Chest Computed Tomography in Patients with Different COVID-19 Variants Prediction Model on Disease Recurrence for Low-Risk Resected Stage I Lung Adenocarcinoma TB Control in Primary Health Care Sectors in West China: Status and Barriers from Organizational and Patient Perspectives Pathways to Impact of Interventions to Reduce Tuberculosis-Related Stigma: A Structured Literature Review and Conceptual Framework Clinical Characteristics in Pulmonary Tuberculosis Complicated with Chronic Kidney Disease |
|
18:10 – 18:20 |
Closing Ceremony |
||